Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.12 - $1.88 $7,115 - $11,943
-6,353 Reduced 22.54%
21,830 $24,000
Q2 2023

Aug 14, 2023

BUY
$1.31 - $2.04 $21,937 - $34,161
16,746 Added 146.42%
28,183 $45,000
Q1 2023

May 08, 2023

BUY
$1.45 - $2.95 $16,560 - $33,691
11,421 Added 71381.25%
11,437 $17,000
Q4 2022

Feb 13, 2023

SELL
$2.02 - $3.25 $39,042 - $62,816
-19,328 Reduced 99.92%
16 $0
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $4,229 - $6,776
-2,158 Reduced 10.04%
19,344 $40,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $468,796 - $952,018
-360,613 Reduced 94.37%
21,502 $42,000
Q1 2022

May 13, 2022

SELL
$2.35 - $3.47 $607,446 - $896,953
-258,488 Reduced 40.35%
382,115 $940,000
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $5,807 - $11,416
-1,989 Reduced 0.31%
640,603 $2.06 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $2.93 Million - $3.91 Million
589,236 Added 1104.35%
642,592 $3.37 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $119,347 - $255,943
46,620 Added 692.1%
53,356 $293,000
Q1 2021

May 13, 2021

BUY
$2.69 - $5.25 $9,240 - $18,033
3,435 Added 104.06%
6,736 $18,000
Q4 2020

Feb 12, 2021

SELL
$3.17 - $4.49 $529 - $749
-167 Reduced 4.82%
3,301 $11,000
Q3 2020

Nov 12, 2020

BUY
$2.98 - $5.2 $420 - $733
141 Added 4.24%
3,468 $14,000
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $3,249 - $6,016
1,419 Added 74.37%
3,327 $13,000
Q1 2020

May 13, 2020

BUY
$1.92 - $4.39 $3,519 - $8,046
1,833 Added 2444.0%
1,908 $5,000
Q4 2019

Feb 14, 2020

SELL
$2.41 - $4.4 $976 - $1,782
-405 Reduced 84.38%
75 $1,000
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $6,761 - $9,784
-3,116 Reduced 86.65%
480 $1,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $1,421 - $1,708
562 Added 18.52%
3,596 $11,000
Q1 2019

May 10, 2019

BUY
$2.51 - $3.73 $7,615 - $11,316
3,034 New
3,034 $9,000
Q2 2018

Aug 10, 2018

SELL
$2.26 - $4.65 $4,741 - $9,755
-2,098 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$3.51 - $6.04 $7,363 - $12,671
2,098 New
2,098 $10,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.